BioCentury
ARTICLE | Financial News

Bicycle raising L20M A round

October 15, 2014 1:45 AM UTC

Bicycle Therapeutics Ltd. (Cambridge, U.K.) raised an undisclosed amount of a planned L20 million ($32.2 million) series A round from existing investors Atlas Venture; Novartis Venture Fund; SR One; SV Life Sciences; and Astellas Venture Management.

Bicycle is developing a pipeline of bicycle peptides, which are created by linking chemically modified linear peptides to create a structure with two variable region peptide loops. ...